Krystal Biotech Inc (KRYS):製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Krystal Biotech Inc (KRYS) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C9413
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:36
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Krystal Biotech Inc (Krystal Biotech) is a drug development company that uses gene therapy to develop novel treatments for skin diseases. The company’s pipeline products include KB103, KB105, and KB200. Its products are used for the treatment of dystrophic EB, TGM1-deficient autosomal recessive congenital ichthyosis, and chronic wounds, among others. The company also utilizes the STAR-D platform to develop treatments for rare orphan dermatological indications caused by the absence of a single gene. Krystal Biotech is headquartered in Pittsburgh, Pennsylvania, the US.

Krystal Biotech Inc (KRYS) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Krystal Biotech Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Krystal Biotech Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Krystal Biotech Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Krystal Biotech Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Krystal Biotech Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Krystal Biotech Inc, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
Krystal Biotech Raises USD11.25 Million in Venture Financing 10
Private Equity 11
Frazier Healthcare Partners to Invest USD10 Million in Krystal Biotech 11
Equity Offering 12
Krystal Biotech Raises USD69 Million in Public Offering of Shares 12
Krystal Biotech Raises USD0.8 Million in Private Placement of Shares 14
Krystal Biotech Raises USD45.54 Million in IPO 15
Krystal Biotech Raises USD0.5 Million in Private Placement of Units 16
Krystal Biotech Raises USD0.7 Million in Private Placement of Units 17
Krystal Biotech Raises USD0.1 Million in Private Placement of Units 18
Debt Offering 19
Krystal Biotech Raises USD0.2 Million in Private Placement of 6% Note Due 2018 19
Krystal Biotech Raises USD0.7 Million in Private Placement of 6% Note Due 2018 20
Krystal Biotech Raises USD0.2 Million in Private Placement of 6% Note Due 2018 21
Krystal Biotech Raises USD1.24 Million in Private Placement of Notes 22
Krystal Biotech Raises USD0.3 Million in Private Placement of Notes 23
Krystal Biotech Raises USD1.4 Million in Private Placement of Notes 24
Krystal Biotech Raises USD0.4 Million in Private Placement of 6% Note Due 2018 25
Krystal Biotech Raises USD0.41 Million in Private Placement of Notes 26
Acquisition 27
Sun Pharma Acquires 15.91% Stake in Krystal Biotech 27
Krystal Biotech Inc – Key Competitors 28
Krystal Biotech Inc – Key Employees 29
Krystal Biotech Inc – Locations And Subsidiaries 30
Head Office 30
Recent Developments 31
Financial Announcements 31
Nov 05, 2018: Krystal Biotech reports third quarter 2018 financial results and provides corporate update 31
Aug 06, 2018: Krystal Biotech announces second quarter 2018 financial results 32
May 07, 2018: Krystal Biotech Reports First Quarter 2018 Financial Results and Provides Corporate Update 33
Mar 12, 2018: Krystal Biotech Announces 2017 Financial Results 34
Nov 13, 2017: Krystal Biotech Announces Third Quarter 2017 Financial Results 35
Appendix 36
Methodology 36
About GlobalData 36
Contact Us 36
Disclaimer 36

List of Tables
Krystal Biotech Inc, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Krystal Biotech Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Krystal Biotech Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Krystal Biotech Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Krystal Biotech Inc, Deals By Therapy Area, 2012 to YTD 2018 8
Krystal Biotech Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Krystal Biotech Raises USD11.25 Million in Venture Financing 10
Frazier Healthcare Partners to Invest USD10 Million in Krystal Biotech 11
Krystal Biotech Raises USD69 Million in Public Offering of Shares 12
Krystal Biotech Raises USD0.8 Million in Private Placement of Shares 14
Krystal Biotech Raises USD45.54 Million in IPO 15
Krystal Biotech Raises USD0.5 Million in Private Placement of Units 16
Krystal Biotech Raises USD0.7 Million in Private Placement of Units 17
Krystal Biotech Raises USD0.1 Million in Private Placement of Units 18
Krystal Biotech Raises USD0.2 Million in Private Placement of 6% Note Due 2018 19
Krystal Biotech Raises USD0.7 Million in Private Placement of 6% Note Due 2018 20
Krystal Biotech Raises USD0.2 Million in Private Placement of 6% Note Due 2018 21
Krystal Biotech Raises USD1.24 Million in Private Placement of Notes 22
Krystal Biotech Raises USD0.3 Million in Private Placement of Notes 23
Krystal Biotech Raises USD1.4 Million in Private Placement of Notes 24
Krystal Biotech Raises USD0.4 Million in Private Placement of 6% Note Due 2018 25
Krystal Biotech Raises USD0.41 Million in Private Placement of Notes 26
Sun Pharma Acquires 15.91% Stake in Krystal Biotech 27
Krystal Biotech Inc, Key Competitors 28
Krystal Biotech Inc, Key Employees 29

List of Figures
Krystal Biotech Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Krystal Biotech Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Krystal Biotech Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Krystal Biotech Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Krystal Biotech Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Krystal Biotech Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Krystal Biotech Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Krystal Biotech Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Krystal Biotech Inc (KRYS):製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • FLSmidth & Co. A/S:企業の戦略・SWOT・財務情報
    FLSmidth & Co. A/S - Strategy, SWOT and Corporate Finance Report Summary FLSmidth & Co. A/S - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Timberwest Forest Corporation
    Timberwest Forest Corporation - Strategy, SWOT and Corporate Finance Report Summary Timberwest Forest Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • MS&AD Insurance Group Holdings, Inc.:企業の戦略・SWOT・財務情報
    MS&AD Insurance Group Holdings, Inc. - Strategy, SWOT and Corporate Finance Report Summary MS&AD Insurance Group Holdings, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysi …
  • Merck & Co., Inc.:企業のM&A・事業提携・投資動向
    Merck & Co., Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Merck & Co., Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), div …
  • Gemphire Therapeutics Inc (GEMP):製薬・医療:M&Aディール及び事業提携情報
    Summary Gemphire Therapeutics Inc (Gemphire), formerly Michigan Life Therapeutics LLC, is a clinical stage biopharmaceutical company that develops and commercializes therapies for patients with cardiometabolic disorders, including dyslipidemia and non-alcoholic steatohepatitis (NASH). Its lead produ …
  • North China Pharmaceutical Co Ltd (600812):製薬・医療:M&Aディール及び事業提携情報
    Summary North China Pharmaceutical Co Ltd (NCPC), a subsidiary of North China Pharmaceutical Group Corp is a pharmaceutical company that develops, produces and sells novel drugs and pharmaceutical related products. The company offers preparation products, nutrition, pharmaceutical raw materials and …
  • Nautilus Marine Services Plc (NAUT):石油・ガス:M&Aディール及び事業提携情報
    Summary Nautilus Marine Services Plc (Nautilus Marine Services), formerly Global Energy Development PLC is an oil and gas company that offers petroleum production and oil and gas exploration and development services. The company’s services include production, drilling, and exploration of properties, …
  • Helsinn Healthcare SA:企業のM&A・事業提携・投資動向
    Helsinn Healthcare SA - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Helsinn Healthcare SA Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M …
  • Checkmate Pharmaceuticals Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Checkmate Pharmaceuticals Inc (Checkmate Pharmaceuticals) is a clinical stage company that discovers and develops immunotherapies to provide new treatment options for patients and the healthcare providers. The company’s lead product candidate, CMP-001, is a CpG oligonucleotides (CpG-A ODN) t …
  • RainDance Technologies Inc:医療機器:M&Aディール及び事業提携情報
    Summary RainDance Technologies Inc (RDT), a subsidiary of Bio-Rad Laboratories Inc is a developer of genomic tools for non-invasive liquid biopsy applications. The company’s products include RainDrop Plus, a digital PCR system that provides picoliter droplets for multiplex detection of HIV and DNA; …
  • The Nature’s Bounty Co:企業の戦略的SWOT分析
    The Nature's Bounty Co - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • BNP Paribas SA:企業のM&A・事業提携・投資動向
    BNP Paribas SA - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's BNP Paribas SA Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestmen …
  • Fomento de Construcciones y Contratas S.A.:戦略・SWOT・企業財務分析
    Fomento de Construcciones y Contratas S.A. - Strategy, SWOT and Corporate Finance Report Summary Fomento de Construcciones y Contratas S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, …
  • Brainsway Ltd (BRIN):企業の財務・戦略的SWOT分析
    Summary Brainsway Ltd (Brainsway) is a medical device company that develops and markets transcranial magnetic stimulation systems and noninvasive medical device for treatment of neurological and psychopathological disorders. The company provides deep transcranial magnetic stimulation products. It of …
  • Symetra Life Insurance Company:企業の戦略・SWOT・財務情報
    Symetra Life Insurance Company - Strategy, SWOT and Corporate Finance Report Summary Symetra Life Insurance Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Bob Evans Farms, Inc.:企業の戦略・SWOT・財務情報
    Bob Evans Farms, Inc. - Strategy, SWOT and Corporate Finance Report Summary Bob Evans Farms, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • The Clorox Company:戦略・SWOT・企業財務分析
    The Clorox Company - Strategy, SWOT and Corporate Finance Report Summary The Clorox Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Amphenol Corp (APH):企業の財務・戦略的SWOT分析
    Amphenol Corp (APH) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Italcementi S.p.A:企業の戦略的SWOT分析
    Italcementi S.p.A - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and serv …
  • Galp Energia SGPS SA (GALP)-エネルギー分野:企業M&A・提携分析
    Summary Galp Energia SGPS S.A. (Galp Energia) is an integrated oil and natural gas company. It explores for, develops and produces crude oil and natural gas; refines crude oil and markets refined petroleum products. The company also imports, transports and distributes natural gas. It conducts the na …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆